Full name
SWISSPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
SWISSPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JAGIELLOŃSKA 46, 10-273 OLSZTYN
TAX ID7393917028
Rate company:
SWISSPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7393917028
KRS0000740469
Share capital5,000.00 zł
address
UL. JAGIELLOŃSKA 46, 10-273 OLSZTYN
Website
www.swisspharm.com.plCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7393917028
REGON
380794184
KRS
0000740469
Legal form
limited liability company
Register Address
UL. JAGIELLOŃSKA 46, 10-273 OLSZTYN
Date of registration in KRS
2018-07-19
Date of commencement of economic activity
2018-07-19
Act signature
RDF/695923/25/92
Website
WWW.SWISSPHARM.COM.PL
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
10 - Manufacture of food products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46.3 - Wholesale trade of food, beverages, and tobacco products
70 - Head office activities and management consultancy
73 - Advertising, market research and public relations
Payer VAT status
Active
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | 30,5 | 1,2 | -0,5 | -140,3 |
EBITDA | 30,5 | 1,5 | -0,5 | -131,8 |
Short time liabilities | 4,8 | 0 | 0 | 0 |
Equity capital | 66,7 | 67,9 | 67,2 | -1 |
Operating profit (EBIT) | 30,5 | 1,5 | -0,5 | -131,8 |
Assets | 71,5 | 67,9 | 67,2 | -1 |
Net profit (loss) | 27,7 | 1 | -0,5 | -146,9 |
Cash | 6,3 | 0,8 | 0,1 | -86,3 |
Liabilities and provisions for liabilities | 4,8 | 0 | 0 | 0 |
Net income from sale | 56,6 | 2,2 | 30,1 | 1241,6 |
Working assets | 71,5 | 67,9 | 67,2 | -1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 41,6 | 1,5 | -0,7 | -2,2 |
Equity capital to total assets | 93,2 | 100 | 100 | 0 |
Gross profit margin | 53,8 | 54,5 | -1,6 | -56,1 |
EBITDA Margin | 53,8 | 69 | -1,6 | -70,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 31 | 0 | 0 | 0 |
Current financial liquidity indicator | 14.804422378540039 | -51,8 | ||
Net dept to EBITDA | -0.20634512603282928 | -0.49820446968078613 | 0.21396616101264954 | 0,7 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download docx01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download xmlShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Med Lux
Janów Lubelski
NTRADE
Marcinowice
Gedeon Richter Polska sp. z o.o.
Grodzisk Mazowiecki
Marek Mazurkiewicz
Zabrze
Cannabis Sklep
Świętochłowice, woj. śląskie, Polska
HS Medical Poland
Tychy
KGU Konsult Wojciech Guzowski
Warszawa
Katarzyna Poleszak
Toruń